These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 12097382

  • 21. The adaptor molecule TIRAP provides signalling specificity for Toll-like receptors.
    Horng T, Barton GM, Flavell RA, Medzhitov R.
    Nature; 2002 Nov 21; 420(6913):329-33. PubMed ID: 12447442
    [Abstract] [Full Text] [Related]

  • 22. Toll gates and traffic arteries: from endothelial TLR2 to atherosclerosis.
    Mullaly SC, Kubes P.
    Circ Res; 2004 Oct 01; 95(7):657-9. PubMed ID: 15459086
    [No Abstract] [Full Text] [Related]

  • 23. Transcriptional regulation of the human toll-like receptor 2 gene in monocytes and macrophages.
    Haehnel V, Schwarzfischer L, Fenton MJ, Rehli M.
    J Immunol; 2002 Jun 01; 168(11):5629-37. PubMed ID: 12023360
    [Abstract] [Full Text] [Related]

  • 24. Micrococci and peptidoglycan activate TLR2-->MyD88-->IRAK-->TRAF-->NIK-->IKK-->NF-kappaB signal transduction pathway that induces transcription of interleukin-8.
    Wang Q, Dziarski R, Kirschning CJ, Muzio M, Gupta D.
    Infect Immun; 2001 Apr 01; 69(4):2270-6. PubMed ID: 11254583
    [Abstract] [Full Text] [Related]

  • 25. Cutting edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection.
    Takeuchi O, Hoshino K, Akira S.
    J Immunol; 2000 Nov 15; 165(10):5392-6. PubMed ID: 11067888
    [Abstract] [Full Text] [Related]

  • 26. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages.
    Toshchakov V, Jones BW, Perera PY, Thomas K, Cody MJ, Zhang S, Williams BR, Major J, Hamilton TA, Fenton MJ, Vogel SN.
    Nat Immunol; 2002 Apr 15; 3(4):392-8. PubMed ID: 11896392
    [Abstract] [Full Text] [Related]

  • 27. Dual role of TLR2 and myeloid differentiation factor 88 in a mouse model of invasive group B streptococcal disease.
    Mancuso G, Midiri A, Beninati C, Biondo C, Galbo R, Akira S, Henneke P, Golenbock D, Teti G.
    J Immunol; 2004 May 15; 172(10):6324-9. PubMed ID: 15128822
    [Abstract] [Full Text] [Related]

  • 28. Mycobacterium tuberculosis and Mycobacterium avium inhibit IFN- gamma -induced gene expression by TLR2-dependent and independent pathways.
    Lafuse WP, Alvarez GR, Curry HM, Zwilling BS.
    J Interferon Cytokine Res; 2006 Aug 15; 26(8):548-61. PubMed ID: 16881865
    [Abstract] [Full Text] [Related]

  • 29. Cutting edge: in vivo induction of integrated HIV-1 expression by mycobacteria is critically dependent on Toll-like receptor 2.
    Báfica A, Scanga CA, Schito ML, Hieny S, Sher A.
    J Immunol; 2003 Aug 01; 171(3):1123-7. PubMed ID: 12874196
    [Abstract] [Full Text] [Related]

  • 30. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway.
    Bulut Y, Faure E, Thomas L, Karahashi H, Michelsen KS, Equils O, Morrison SG, Morrison RP, Arditi M.
    J Immunol; 2002 Feb 01; 168(3):1435-40. PubMed ID: 11801686
    [Abstract] [Full Text] [Related]

  • 31. Cell activation by Porphyromonas gingivalis lipid A molecule through Toll-like receptor 4- and myeloid differentiation factor 88-dependent signaling pathway.
    Ogawa T, Asai Y, Hashimoto M, Takeuchi O, Kurita T, Yoshikai Y, Miyake K, Akira S.
    Int Immunol; 2002 Nov 01; 14(11):1325-32. PubMed ID: 12407023
    [Abstract] [Full Text] [Related]

  • 32. Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration.
    Seki E, Tsutsui H, Iimuro Y, Naka T, Son G, Akira S, Kishimoto T, Nakanishi K, Fujimoto J.
    Hepatology; 2005 Mar 01; 41(3):443-50. PubMed ID: 15723296
    [Abstract] [Full Text] [Related]

  • 33. Cutting edge: preferentially the R-stereoisomer of the mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a toll-like receptor 2- and MyD88-dependent signaling pathway.
    Takeuchi O, Kaufmann A, Grote K, Kawai T, Hoshino K, Morr M, Mühlradt PF, Akira S.
    J Immunol; 2000 Jan 15; 164(2):554-7. PubMed ID: 10623793
    [Abstract] [Full Text] [Related]

  • 34. The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages.
    Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M, Marsche G, Young MF, Mihalik D, Götte M, Malle E, Schaefer RM, Gröne HJ.
    J Clin Invest; 2005 Aug 15; 115(8):2223-33. PubMed ID: 16025156
    [Abstract] [Full Text] [Related]

  • 35. Porin of Shigella dysenteriae enhances Toll-like receptors 2 and 6 of mouse peritoneal B-2 cells and induces the expression of immunoglobulin M, immunoglobulin G2a and immunoglobulin A.
    Ray A, Biswas T.
    Immunology; 2005 Jan 15; 114(1):94-100. PubMed ID: 15606799
    [Abstract] [Full Text] [Related]

  • 36. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling.
    Yamamoto M, Sato S, Mori K, Hoshino K, Takeuchi O, Takeda K, Akira S.
    J Immunol; 2002 Dec 15; 169(12):6668-72. PubMed ID: 12471095
    [Abstract] [Full Text] [Related]

  • 37. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4.
    Yamamoto M, Sato S, Hemmi H, Sanjo H, Uematsu S, Kaisho T, Hoshino K, Takeuchi O, Kobayashi M, Fujita T, Takeda K, Akira S.
    Nature; 2002 Nov 21; 420(6913):324-9. PubMed ID: 12447441
    [Abstract] [Full Text] [Related]

  • 38. Toll-like receptor 6 senses Mycobacterium avium and is required for efficient control of mycobacterial infection.
    Marinho FA, de Paula RR, Mendes AC, de Almeida LA, Gomes MT, Carvalho NB, Oliveira FS, Caliari MV, Oliveira SC.
    Eur J Immunol; 2013 Sep 21; 43(9):2373-85. PubMed ID: 23716075
    [Abstract] [Full Text] [Related]

  • 39. An angiogenic switch in macrophages involving synergy between Toll-like receptors 2, 4, 7, and 9 and adenosine A(2A) receptors.
    Pinhal-Enfield G, Ramanathan M, Hasko G, Vogel SN, Salzman AL, Boons GJ, Leibovich SJ.
    Am J Pathol; 2003 Aug 21; 163(2):711-21. PubMed ID: 12875990
    [Abstract] [Full Text] [Related]

  • 40. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide.
    Tobian AA, Potter NS, Ramachandra L, Pai RK, Convery M, Boom WH, Harding CV.
    J Immunol; 2003 Aug 01; 171(3):1413-22. PubMed ID: 12874233
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.